uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 28, 2015

Settlement Restricts Label Claims for Certain Glucosamine Supplements

On March 23, 2015 a federal judge approved a settlement agreement which will require the maker of glucosamine products (Perrigo Co.) sold under Walmart, Target, Walgreens, GNC and other brands, to refrain from claiming its products can repair, strengthen, or rebuild cartilage, including using terms such as "rebuild, renew, regrow, grow, add to or regenerate cartilage" for a period of two years.

The lawsuit against Perrigo charged that these claims were deceptive and misleading due to a lack of evidence. The settlement stipulates that Perrigo can seek to have the restriction on label claims modified should the company become aware of additional evidence that would support such claims.

(See a complete list of brands and products included in the settlement here).

The settlement also provides for refunds to consumers who purchased the affected products between November 1, 2005 and August 1, 2014 and who submitted a claim form before the November 14, 2014 deadline.

For more information about the evidence for glucosamine, and our tests of popular joint health products, see's Review of Glucosamine, Chondroitin, MSM and Boswellia Supplements for Joint Health.

See Related Warnings:

Glucosamine Class-Action Settlement Reversed by Appeals Court

Glucosamine Legal Settlement Over Labeling -- Many Products Covered

Seller of Joint Pain Supplement Warned for Drug Claims

Seller of Joint Supplement Warned for Manufacturing Violations and Drug Claims

For more about the settlement, use the link below.